CVS vs UNH
CVS and UNH side by side — valuation & fundamentals (public data).
Key statistics
| Metric | CVSCVS HEALTH CORPORATION | UNHUnitedHealth Group Incorporated |
|---|---|---|
| Market cap | $120.81B | $337.43B |
| P/E (TTM) | 24.9 | 24.2 |
| P/B | 1.52 | 10.22 |
| P/S | 0.3x | 0.8x |
| Dividend yield | 2.81% | 2.35% |
| Revenue | $415.09B(TTM) | $450.13B(TTM) |
| Revenue growth (YoY) | 7.8% | 11.8% |
| Net income | $4.89B(TTM) | $14.12B(TTM) |
| Earnings growth (YoY) | -61.7% | -16.3% |
| EPS, diluted | $3.79(TTM) | $15.56(TTM) |
| EBIT margin | 1.2% | 4.2% |
| ROE | 2.2% | 36.5% |
| ROIC | 2.9% | 21.3% |
| Piotroski F | 6/9 | — |
| 1y total return | +32.2% | +10.5% |
Figures from SEC filings · for reference only · not investment advice
Growth of $10,000: CVS vs UNH
| Metric | CVS | UNH |
|---|---|---|
| End value | $12.3K | $34.5K |
| Total return | +23.2% | +245.4% |
| CAGR | +2.0% | +12.7% |
| Volatility | 28.7% | 29.9% |
| Sharpe | 0.07 | 0.42 |
| Sortino | 0.10 | 0.57 |
| Max drawdown | -56.8% | -61.4% |
Based on 2600 common trading days, 2016-05-12 → 2026-09-15 · risk-free 4.11% (current short-Treasury, held constant)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)